Contract Research Organization WCCT Global Announces Dr. John Hong to Lead Gastroenterology Clinical Research
Dr John Hong joins WCCT Global as Leading Private Investigator for Gastroenterology Clinical Trials
COSTA MESA, Calif., April 29, 2014 /PRNewswire-iReach/ — Today, WCCT Global announced that Dr. John Hong has joined the organization as the Head of GI Clinical Research. John Hong, MD, MBA brings many years of GI Clinical Care and Research experience to the role. He is a graduate of the University Of Miami School Of Medicine and completed his Internal Medicine Residency and Gastroenterology Fellowship at the University of Chicago Hospitals & Pritzker School of Medicine. He is a Diplomate of the American Board of Internal Medicine with subspecialty certification in Gastroenterology. His major fields of GI research have been in HCV and IBD. Dr. Hong will serve as Principal Investigator for Gastroenterology clinical trials for WCCT Global and therefore greatly expand the WCCT Global research capabilities by virtue of his vast experience in the field of GI research and his access to patients suffering from multiple GI disorders.
Moreover, Dr. Hong has obtained an M.B.A from the University of Chicago Graduate School of Business and is CEO of American Cardiac Education Specialists (ACES). Dr. Hong remains an active member of the American College of Gastroenterology, Southern California Society of Gastroenterology and American Society of Gastrointestinal Endoscopy. With Dr. Hong joining WCCT Global, he brings his capabilities of 11 sites & large network of patients to WCCT Global.
More About WCCT Global:
WCCT Global is a multi-site, full service pharmaceutical contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you would like more information about WCCT Global and their Gastroenterology clinical trial capabilites, CLICK HERE
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global